[breadcrumb_custom]

An Overview of Revelation Biosciences Inc (NASDAQ: REVB)’s Stock Performance and Outlook

In the latest trading session, 0.4 million Revelation Biosciences Inc (NASDAQ:REVB) shares changed hands as the company’s beta touched 0.20. With the company’s most recent per share price at $2.90 changing hands around $0.14 or 5.07% at last look, the market valuation stands at $1.16M. REVB’s current price is a discount, trading about -2931.03% off its 52-week high of $87.90. The share price had its 52-week low at $2.40, which suggests the last value was 17.24% up since then. When we look at Revelation Biosciences Inc’s average trading volume, we note the 10-day average is 0.92 million shares, with the 3-month average coming to 9.60.

Revelation Biosciences Inc (NASDAQ:REVB) trade information

Instantly REVB is in green as seen in intraday trades today. With action 11.54%, the performance over the past five days has been green. The jump to weekly highs of 3.09 added 5.07% to the stock’s daily price. The company’s shares are showing year-to-date downside of -80.69%, with the 5-day performance at 11.54% in the green. However, in the 30-day time frame, Revelation Biosciences Inc (NASDAQ:REVB) is -79.61% down. Looking at the short shares, we see there were 0.12 million shares sold at short interest cover period of 0.31 days.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Revelation Biosciences Inc (REVB) estimates and forecasts

Data shows that the Revelation Biosciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -86.78% over the past 6 months, a 105.87% in annual growth rate that is considerably higher than the industry average of 15.60%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2024 revenue estimates. The rating firms predict current quarter revenue for Revelation Biosciences Inc will rise 74.00%, while the growth in revenue is estimated to hit -117.20% for the next quarter.

Revelation Biosciences Inc (NASDAQ:REVB)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 1.33% of Revelation Biosciences Inc shares while 9.85% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 9.99%. There are 9.85% institutions holding the Revelation Biosciences Inc stock share, with Sabby Management, LLC the top institutional holder. As of Jun 29, 2023, the company held 5.61% of the shares, roughly 0.35 million REVB shares worth $0.33 million.

Walleye Capital LLC holds the second largest percentage of outstanding shares, with 4.91% or 0.31 million shares worth $0.29 million as of Jun 29, 2023.

With 600.0 shares estimated at $564.0 under it, the former controlled 0.01% of total outstanding shares.

On Key

Related Posts